GB201404044D0 - Composition and use of lactobacillus reuteri gmnl-89 in treating type 2 diabetes - Google Patents

Composition and use of lactobacillus reuteri gmnl-89 in treating type 2 diabetes

Info

Publication number
GB201404044D0
GB201404044D0 GBGB1404044.8A GB201404044A GB201404044D0 GB 201404044 D0 GB201404044 D0 GB 201404044D0 GB 201404044 A GB201404044 A GB 201404044A GB 201404044 D0 GB201404044 D0 GB 201404044D0
Authority
GB
United Kingdom
Prior art keywords
diabetes
composition
lactobacillus reuteri
treating type
reuteri gmnl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB1404044.8A
Other versions
GB2524474A (en
GB2524474B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genmont Biotech Inc
Original Assignee
Genmont Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genmont Biotech Inc filed Critical Genmont Biotech Inc
Priority to GB1404044.8A priority Critical patent/GB2524474B/en
Publication of GB201404044D0 publication Critical patent/GB201404044D0/en
Publication of GB2524474A publication Critical patent/GB2524474A/en
Application granted granted Critical
Publication of GB2524474B publication Critical patent/GB2524474B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB1404044.8A 2014-03-07 2014-03-07 Composition and use of lactobacillus reuteri GMNL-89 in treating type 2 diabetes Active GB2524474B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1404044.8A GB2524474B (en) 2014-03-07 2014-03-07 Composition and use of lactobacillus reuteri GMNL-89 in treating type 2 diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1404044.8A GB2524474B (en) 2014-03-07 2014-03-07 Composition and use of lactobacillus reuteri GMNL-89 in treating type 2 diabetes

Publications (3)

Publication Number Publication Date
GB201404044D0 true GB201404044D0 (en) 2014-04-23
GB2524474A GB2524474A (en) 2015-09-30
GB2524474B GB2524474B (en) 2018-01-31

Family

ID=50554684

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1404044.8A Active GB2524474B (en) 2014-03-07 2014-03-07 Composition and use of lactobacillus reuteri GMNL-89 in treating type 2 diabetes

Country Status (1)

Country Link
GB (1) GB2524474B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112075638A (en) * 2019-06-14 2020-12-15 丰华生物科技股份有限公司 Food compositions and pharmaceutical compositions comprising a hypoglycemic lactic acid bacterial strain
CN114990004A (en) * 2022-04-19 2022-09-02 青岛大学 Secretory immunoglobulin A encapsulated lactobacillus reuteri and application thereof in preventing and treating gestational diabetes

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107475117A (en) * 2017-07-03 2017-12-15 桐乡恒基生物股份有限公司 A kind of freeze drying protectant for lactobacillus reuteri and lyophilized store method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6942857B2 (en) * 2002-08-09 2005-09-13 Bioneer Corporation Microorganisms for preventing and/or treating obesity or diabetes mellitus
DK2419114T4 (en) * 2009-05-01 2019-05-27 Uas Laboratories Llc Bacterial compositions for the prophylaxis and treatment of degenerative diseases
US8298526B2 (en) * 2010-06-02 2012-10-30 Genmont Biotech Inc. Lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112075638A (en) * 2019-06-14 2020-12-15 丰华生物科技股份有限公司 Food compositions and pharmaceutical compositions comprising a hypoglycemic lactic acid bacterial strain
CN114990004A (en) * 2022-04-19 2022-09-02 青岛大学 Secretory immunoglobulin A encapsulated lactobacillus reuteri and application thereof in preventing and treating gestational diabetes
CN114990004B (en) * 2022-04-19 2023-09-15 尚品健康科技(青岛)有限公司 Secretory immunoglobulin A-packaged lactobacillus reuteri and application thereof in preventing and treating gestational diabetes

Also Published As

Publication number Publication date
GB2524474A (en) 2015-09-30
GB2524474B (en) 2018-01-31

Similar Documents

Publication Publication Date Title
HRP20190369T1 (en) Dihydrobenzofuran compounds useful in the treatment of diabetes and obesity
PL3212208T3 (en) Use of l. reuteri for prevention or treatment of microbiota dysbiosis in early life
IL247775A0 (en) In vivo and in vitro use of graphene
SG10202002593SA (en) Activated bifidobacteria and methods of use thereof
GB201411197D0 (en) Composition and use thereof
HK1218312A1 (en) Composition and use thereof in sequence determination and mutation detection
PL3018183T3 (en) Haloolefin-based composition and use thereof
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
ZA201900869B (en) Use of probiotics in the treatment and/or prevention of atopic dermatitis
HK1245658A1 (en) Nutritional composition useful in the treatment of ibd patients
ZA201704726B (en) Peptides and their use in the treatment of skin
GB2548930B (en) Heat-inactivated Lactobacillus rhamnosis GMNL-464 for use in the prevention of halitosis
PL3157354T3 (en) Composition in the form of compacted particles and use thereof
GB2524474B (en) Composition and use of lactobacillus reuteri GMNL-89 in treating type 2 diabetes
HUE062482T2 (en) Preparation comprising lactobacillus reuteri and citrate for medical use
HK1244821A1 (en) Peptides for use in treatment and diagnosis of type 1 diabetes
GB201411196D0 (en) Composition and use thereof
PL3454873T3 (en) Probiotic composition and uses thereof
LT3168292T (en) New lactobacillus plantarum strain amt14 and composition containing the strain of lactobacillus plantarum amt14
GB201502240D0 (en) Composition and use of lactobacillus reuteri GMNL-263 in decreasing blood lipid levels
HK1258843A1 (en) Glycolipid compounds and their uses in the treatment of tumours
GB2530711B (en) Security composition and use thereof
GB201502565D0 (en) Composition and use in treatment of a detached retina
ZA201403582B (en) Composition for use in treatment of anemia and low blood pressure
GB201409978D0 (en) Novel compounds and their use in therapy